rss
DTB 1996;34:53-55 doi:10.1136/dtb.1996.34753
  • Articles

▼Meropenem - an advantageous antibiotic?

  • Relevant BNF section: 5.1.2

Abstract

Meropenem (Meronem - Zeneca) follows imipenem1 as the second carbapenem β-lactam antibiotic to be marketed in the UK. Does meropenem offer therapeutic advantages, particularly when compared with imipenem?

Footnotes